Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107162932B reveals a one-step benzonitrile synthesis using ionic liquids. Achieve high purity, reduced corrosion, and scalable manufacturing for pharmaceutical intermediates.
Patent CN107382769A reveals a low-cost synthesis for trifluoro butene intermediates. This method offers significant supply chain stability and cost reduction advantages.
Novel synthesis of chiral (R)-alpha-phenylethylamine acetate via cobalt complex. High yield Henry reaction catalyst for pharmaceutical intermediates manufacturing.
Patent CN116178431A discloses advanced N,N,P ligands enabling high enantioselectivity in radical reactions. Discover cost-effective synthesis and supply chain advantages for pharma intermediates.
Patent CN102417495B reveals copper squarylate catalysis for furil. Offers cost reduction and supply chain reliability for electronic chemical manufacturing.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Patent CN101142164B details a cost-effective route to Synthon A using planar chiral diphosphine catalysts, offering high ee and scalability for API manufacturing.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108863847A details high-yield perfluoroisobutyronitrile production. Offers eco-friendly SF6 alternative with scalable manufacturing and supply chain stability.
Novel axon-labile chiral ligands enable efficient asymmetric catalysis without resolution. Reduces cost and waste in pharmaceutical intermediate manufacturing.
Patent CN102391124A reveals a high-yield POCl3 catalyzed route for light stabilizers. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN103194501B reveals enzymatic synthesis for high purity chiral amino acids. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN115232164B reveals a visible-light catalyzed method for sulfonyl thiophosphates. This process offers mild conditions and high atom economy for reliable agrochemical intermediate supplier.
Discover a novel preparation method for rosuvastatin calcium intermediates featuring mild conditions, high yield, and superior stereocontrol for reliable pharmaceutical manufacturing.
Patent CN116178428A reveals a safe, high-yield synthesis for P,O-hybrid ligands, eliminating hazardous Grignard reagents for reliable pharmaceutical intermediate supply.
Patent CN119876067B reveals high-activity carbonyl reductase mutants for diltiazem intermediates, offering scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Patent CN115232164B enables efficient sulfonyl thiophosphate production via visible light photocatalysis. Offers cost reduction and supply chain reliability for agrochemical intermediates.
Novel patent method for high-purity thiophene intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing globally.
Patent CN111848628A reveals a green g-C3N4 catalyzed route for high-purity intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.